TFF Pharmaceuticals Hosting Key Opinion Leader Perspectives on Thin Film Freezing Applications
Focus on TFF Tacrolimus for Lung Transplant and TFF in Vaccine Technology Tuesday, June 15th @ 4pm ET AUSTIN, Texas,...
Staff
Premier Health is Launching a Canadian AI Based Recruiting Exchange With Rekruti
MONTREAL, June 07, 2021 (GLOBE NEWSWIRE) -- Premier Health of America Inc. (TSXV: PHA) (“Premier Health” or the “Corporation”), a...
DLH-Supported Projects Named 2021 FedHealthIT Innovation Award Winners
ATLANTA, June 07, 2021 (GLOBE NEWSWIRE) -- DLH Holdings Corp. (NASDAQ: DLHC) (“DLH” or the “Company”), a leading provider of...
Intercept Appoints Andrew Saik as Chief Financial Officer
NEW YORK, June 07, 2021 (GLOBE NEWSWIRE) -- Intercept Pharmaceuticals, Inc. (Nasdaq:ICPT), a biopharmaceutical company focused on the development and...
Genix Pharmaceuticals Corporation Provides a Corporate Update to Shareholders
Vancouver, British Columbia--(Newsfile Corp. - June 7, 2021) - Genix Pharmaceuticals Corporation (TSXV: GENX) ("Genix" or the "Company"). President, Mr....
CENTR Brands Corp. Hires Carlyle Group Executive David Young as CFO
Vancouver, British Columbia--(Newsfile Corp. - June 7, 2021) - CENTR Brands Corp. (CSE: CNTR) (FSE: 303) (OTCQB: CNTRF) (the "Company"),...
Defence Therapeutics Retains the HUS Comprehensive Cancer Center to Optimize Its Accum-T-DM1 ADC Therapeutic
Vancouver, British Columbia--(Newsfile Corp. - June 7, 2021) - Defence Therapeutics Inc. (CSE: DTC) ("Defence" or the "Company") is pleased...
Pharnext Announces a New Financing Through a Convertible Bond Program for a Total Amount up to €81 Million Gross to Extend its Cash Runway and to Continue to Fund its Pivotal Phase III Study
Pharnext Announces a New Financing Through a Convertible Bond Program for a Total Amount up to €81 Million Gross to...
Novartis announces iptacopan met Phase II study primary endpoint in rare kidney disease IgA nephropathy (IgAN)
Phase II primary endpoint results for investigational iptacopan in IgAN demonstrated effective and clinically meaningful reduction of proteinuria1 – a...
Covetrus Integrates Prescription and Practice Management Technologies
Digital scripts drive health, growth and wellness for busy veterinary clinics PORTLAND, Maine--(BUSINESS WIRE)--$CVET--Covetrus® (NASDAQ: CVET), a global leader in...
Health Assurance Acquisition Corp. Receives Expected Notice From Nasdaq Regarding Delayed Quarterly Report
SAN FRANCISCO, June 04, 2021 (GLOBE NEWSWIRE) -- Health Assurance Acquisition Corp. (Nasdaq: HAACU) (the “Company”) today announced that, on May...
Verano Announces Filing of Final Base Shelf Prospectus
THIS NEWS RELEASE IS INTENDED FOR DISTRIBUTION IN CANADA ONLY AND IS NOT INTENDED FOR DISTRIBUTION TO UNITED STATES NEWS...
GigCapital2 Stockholders Approve Business Combinations with UpHealth Holdings, Inc. and Cloudbreak Health, LLC
PALO ALTO, Calif. & DELRAY BEACH, Fla. & COLUMBUS, Ohio--(BUSINESS WIRE)--$GIX--GigCapital2, Inc. (“GigCapital2”) (NYSE: GIX, GIX.U, GIX.RT, and GIX.WS) announced...
With Hundreds of Bio Industry Jobs Open and Company Expansions Underway, Companies Are Investing in Industry-Intensive Training and Professional Development
PORTLAND, Ore.--(BUSINESS WIRE)--#BioPro--With large company expansions such as Micro Systems Engineering’s upcoming Lake Oswego-area advanced automated manufacturing expansion, Genentech’s Hillsboro...
Leveljump to Present at GCFF Virtual Healthcare Conference on June 10, 2021
Toronto, Ontario--(Newsfile Corp. - June 4, 2021) - Leveljump Healthcare Corp. (TSXV: JUMP) (OTCQB: JMPHF) (FSE: 75J) ("Leveljump" or the...
Sanara MedTech Inc. Announces Exclusive Partnership with Pixalere Healthcare Inc. to Advance its Comprehensive Wound and Skin Care Strategy
FORT WORTH, TX / ACCESSWIRE / June 4, 2021 / Sanara MedTech Inc. Based in Fort Worth, Texas, Sanara MedTech...
Celldex Presents Preliminary Data from Ongoing CDX-527 Phase 1 Dose Escalation Trial at the 2021 ASCO Annual Meeting
HAMPTON, N.J., June 04, 2021 (GLOBE NEWSWIRE) -- Celldex Therapeutics, Inc. (NASDAQ:CLDX) today announced preliminary data from the Company’s Phase...
TRACON Pharmaceuticals Presents Data from a Phase 1 Study of Uliledlimab (TJ004309) and Tecentriq® (Atezolizumab) at the American Society of Clinical Oncology Virtual Annual Meeting
SAN DIEGO, June 04, 2021 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals (NASDAQ:TCON), a clinical stage biopharmaceutical company focused on the development...
G1 Therapeutics Presents Data on COSELA™ (trilaciclib) at ASCO on Potential Immune Activation in Patients with Newly Diagnosed Extensive-Stage Small Cell Lung Cancer
RESEARCH TRIANGLE PARK, N.C., June 04, 2021 (GLOBE NEWSWIRE) -- G1 Therapeutics, Inc. (Nasdaq: GTHX), a commercial-stage oncology company, today presented results...
Y-mAbs Announces Update on Omburtamab for DIPG
NEW YORK, June 04, 2021 (GLOBE NEWSWIRE) -- Y-mAbs Therapeutics, Inc. (the “Company” or “Y-mAbs”) (Nasdaq: YMAB) a commercial-stage biopharmaceutical...